A U.S. Food and Drug Administration advisory panel on Friday voted to endorse Johnson & Johnson’s coronavirus vaccine, clearing the way for FDA leaders to grant emergency use authorization amid the ongoing fight against COVID-19.
A U.S. Food and Drug Administration advisory committee on Friday is slated to vote on Johnson & Johnson’s one-dose COVID-19 jab, with the panel expected to recommend that the FDA formally grant the shot emergency use approval in a race to vaccinate as many Americans as possible in the continued fight against the novel coronavirus.
An endorsement from an independent group of experts and an emergency use authorization from the Food and Drug Administration would spark a rollout of up to 4 million jabs across the U.S. early next week.
A coronavirus vaccine developed by Johnson & Johnson could potentially clear U.S. regulatory hurdles over the next day, and authorization would mark the third jab in the country’s arsenal against the novel virus.
Annie’s Homegrown, largely known for its macaroni and cheese, is taking steps to remove a potentially harmful class of chemicals, called ortho-phthalates from its products and packaging materials.
The Food and Drug Administration (FDA) said Thursday it is allowing more flexible shipping and storage temperatures for the Pfizer-BioNTech coronavirus vaccine. The change permits transportation and two-week storage at -25 degrees Celsius to -15 degrees Celsius, which is often found in pharmaceutical freezers and refrigerators.
How would COVID-19 vaccine makers adapt to variants? By tweaking their vaccines, a process that should be easier than coming up with the original shots.
A study published Wednesday in the journal JAMA Internal Medicine suggests that those who have COVID-19 antibodies have a significantly lower risk of reinfection compared to those who do not have them.
New York City health officials on Thursday said there is no evidence showing the newly reported variant, B.1.526, is driving trajectory of infections, reduces vaccine efficacy or results in more severe illness.
Small pet turtles are behind a salmonella outbreak in Pennsylvania, according to state health officials who said at least one person has died as a result.
Pfizer Inc. and BioNTech SE have begun a study testing in people whether the companies’ Covid-19 shot can provide protection against emerging strains of the coronavirus.
California is revamping its plan to help essential workers and seniors in underserved communities get coronavirus vaccinations after officials learned that appointment access codes were leaked to people who were not eligible for the shots.
A coronavirus vaccine developed by Pfizer and BioNTech showed to drop symptomatic COVID-19 by 94%, per new research out of Israel. The peer-reviewed results offer a first look at effectiveness in real-world conditions, and showed consistency with high 95% vaccine efficacy reported during clinical trials.
Researchers studying COVID-19 and its variants across the U.S. have expressed concern over a mutation found in New York City that could diminish the effectiveness of vaccines on the virus.
Moderna on Wednesday announced that the COVID-19 vaccine it recently developed to address a concerning new coronavirus variant first identified in South Africa is ready to be tested in people in clinical trials.
Outbreaks of the common cold could become more commonplace as schools reopen for in-person learning, according to a new report from the Centers for Diease Control and Prevention.
Early data suggests a coronavirus variant first detected in California may be more transmissible, possibly cause more severe disease, and could have an impact on vaccine efficacy.
Five more cases of a rare but potentially serious coronavirus-related inflammatory condition in children have been reported in Virginia, health officials there said.
The U.S. is prepared to send out 3.5 million doses of Johnson & Johnson’s COVID-19 vaccine as early as next week should the FDA grant emergency use authorization on Friday.
The Pfizer and Moderna coronavirus vaccines have been an outstanding success by any measure and represent the quickest return to normal American life, but experts tell Fox News they are worried that mixed government messaging and some skeptical journalism are clouding that message.
Washington state health officials announced Tuesday that a concerning coronavirus variant first detected in South Africa had been found in northwestern King County, home to Seattle.
Clive Davis’ rep told Page Six that the record industry legend would be postponing the second half a planned virtual pre-Grammys party following a Bell’s palsy diagnosis.
The Food and Drug Administration posted documents Wednesday finding a single-dose vaccine developed by Johnson & Johnson had “favorable safety profile with no specific concerns identified that would preclude issuance of an EUA.”
By the middle of this year, all adults in Britain are due to be offered a Covid-19 vaccine in what is on course to be the fastest inoculation rollout in a major Western country. But disease modelers advising the U.K. government recently made a sobering projection: 56,000 more Covid-19 deaths by the summer of next year, even if the country tiptoes out of lockdown and the vaccines work.
A 10-year-old boy in Michigan has undergone four amputations of his hands and legs after a rare bout of a serious coronavirus-related inflammatory condition.